EarlyDiagnostics (EarlyDx) announced PNAS validation of its MethylScan™ platform for multi-disease detection from a single blood sample.
Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Morning Overview on MSN
Study says AI can flag pancreatic cancer years before symptoms
Pancreatic cancer has one of the bleakest survival rates in oncology. Just 13% of patients are alive five years after ...
Weinstein Imaging Associates joins as clinical site to collect breath samples to advance development of a breath test for ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Bottom Line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient’s risk of hepatocellular carcinoma (HCC), ...
OpenAI has launched GPT-Rosalind, an AI model tailored for life sciences, alongside new research from UC San Diego on a machine learning tool that more accurately predicts Type 1 diabetes risk. These ...
Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results